JPRN-UMIN000008218已完成2 期
PhaseII Study of SI-657 in Patients with Enthesopathy (Lateral Epicondylitis) - PhaseII Study of SI-657 in Patients with Enthesopathy (Lateral Epicondylitis)
KAKEN PHARMACEUTICAL CO., LTD/SEIKAGAKU CORPORATIO0 个研究点目标入组 40 人开始时间: 2012年6月21日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients who received local injection or steroid topical treatment at the arm affected with lateral epicondylitis within 2 weeks before the first administration. 2.Patients with pain due to complication other than lateral epicondylitis around the affected site. 3.Patients with infectious risk at the administration site due to skin disease or infection.
研究者
相似试验
已完成
3 期
A confirmatory study of SI-657 in Patients with Enthesopathy (Lateral Epicondylitis, Patellar Tendinitis, Achilles Tendinitis and Plantar Fasciitis)Enthesopathy (Lateral Epicondylitis, Patellar Tendinitis, Achilles Tendinitis and Plantar Fasciitis)JPRN-UMIN000010982KAKEN PHARMACEUTICAL CO., LTD/SEIKAGAKU CORPORATIO540
未知
2 期
Phase IIa Study of S-555739 in Patients with Seasonal Allergic RhinitisSeasonal allergic rhinitisJPRN-jRCT2080221324SHIONOGI & CO., LTD.
未知
2 期
Phase IIb Study of S-555739 in Patients with Seasonal Allergic RhinitisSeasonal allergic rhinitisJPRN-jRCT2080221656SHIONOGI & CO., LTD.
未知
3 期
Phase III Study of S-555739 in Patients with Seasonal Allergic RhinitisSeasonal allergic rhinitisJPRN-jRCT2080222000SHIONOGI & CO., LTD.
未知
3 期
A Phase 3 study of S-474474 in patients with essential hypertensioHypertensionJPRN-jRCT2080221505SHIONOGI & CO., LTD.